GeoVax Labs Inc.

News & Events

Press Releases

In The Media

1. GeoVax Highlights Positive Immune Response Results From GEO-CM04S1 in CLL Patients at the European Hematology Association 2025 Meeting

   NewMediaWire JUN 17, 2025 9:04 AM EDT
   GEO-CM04S1 Demonstrates Superior T Cell Responses Compared to mRNA Vaccine in Phase 2 Trial Among...
   READ ARTICLE

2. GeoVax Receives Favorable European Regulatory Guidance Supporting Streamlined Development Pathway for GEO-MVA

   NewMediaWire JUN 16, 2025 9:04 AM EDT
   Confirms Single Phase 3 Immuno-Bridging Trial Sufficient to Evaluate Efficacy and to Support a Ma...
   READ ARTICLE

3. GeoVax to Participate in BIO International Convention 2025

   NewMediaWire JUN 12, 2025 9:06 AM EDT
   ATLANTA, GA - June 12, 2025 ( NEWMEDIAWIRE ) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage...
   READ ARTICLE

4. GeoVax Responds to WHO's Fourth Declaration of Mpox as a Global Public Health Emergency

   NewMediaWire JUN 11, 2025 9:07 AM EDT
   GEO-MVA Provides Potential Opportunity to Expand Mpox Vaccine Supply Amid Growing U.S. and Global...
   READ ARTICLE

5. GeoVax Announces Upcoming Presentation at the European Hematology Association 2025 Congress Highlighting Positive Immune Response Data for GEO-CM04S1 in CLL Patients

   NewMediaWire JUN 10, 2025 9:06 AM EDT
   ATLANTA, GA - June 10, 2025 ( NEWMEDIAWIRE ) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-sta...
   READ ARTICLE

6. GeoVax Highlights Broad Cross-Protective Immunity of Multi-Antigen COVID-19 Vaccine Candidates at Keystone Symposia

   NewMediaWire JUN 9, 2025 9:06 AM EDT
   Preclinical Studies Demonstrate Durable Protection Against SARS-CoV-2 Variants, Including Omicron...
   READ ARTICLE

7. GeoVax to Showcase Innovative COVID 19 Vaccine Data at the Keystone Symposia on Vaccinology

   NewMediaWire JUN 4, 2025 9:05 AM EDT
   Data from Two Key Studies Highlight Cross‑Reactivity and Broad‑Spectrum Immunity of...
   READ ARTICLE

8. GeoVax Congratulates Bipartisan Senate Action to Onshore Critical Medical Manufacturing

   NewMediaWire MAY 29, 2025 9:06 AM EDT
   Highlights Broad National Support for Domestic Vaccine Resilience and Role of MVA Platform in Pub...
   READ ARTICLE

9. GeoVax Commends FDA's Shift to Risk-Based COVID-19 Vaccination Guidance

   NewMediaWire MAY 27, 2025 11:06 AM EDT
   Highlights Critical Role of Multi-Antigen GEO-CM04S1 in Protecting Vulnerable Populations  ...
   READ ARTICLE

10. GeoVax Applauds EQUIP-A-Pharma Initiative, Reinforces Commitment to Domestic Vaccine Manufacturing and Biodefense Innovation

    NewMediaWire MAY 21, 2025 9:04 AM EDT
    GeoVax’s Advanced MVA Manufacturing Platform Supports ASPR-DARPA Vision for Scalable, AI-I...
    READ ARTICLE